Financial intelligence for Asia's healthcare markets
 
 
Remember me:

China: JLABS launches in Shanghai

Johnson & Johnson Innovation has announced a collaboration with the Shanghai municipal government, Pudong New Area government, and Shanghai Pharma Engine Company to launch a new Johnson & Johnson Innovation, JLABS in Shanghai. The 4,400 square meter facility will be located in Shanghai's Zhangjiang Hi-Tech Park and will open in the second quarter of 2019.

JLABS @ Shanghai will be the first JLABS location established outside of North America and will accommodate up to 50 life science and healthcare startups, both single entrepreneurs and larger companies, focused on innovations across the entire healthcare spectrum, including pharmaceuticals, medical devices and consumer. JLABS @ Shanghai will provide resident innovators with a capital efficient and flexible platform including an extensive network that will enable them to accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients in China and around the world.

"We are excited about the launch of JLABS @ Shanghai, which will be an integral investment in the city's life science ecosystem. It will support entrepreneurship as it relates to science and technology and strengthen our position as a global innovation hub," said Liu Qin, deputy inspector general, science and technology commission, Shanghai municipal government.

Posted on: 08/12/2017 UTC+08:00


News

Singapore health technology start-up X-Zell has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen.
Shanghai-based digital healthcare platform 111 Inc and Hainan Huluwa Pharmaceutical Group Co. have signed a strategic partnership agreement.
Malaysia's healthcare tourism industry is showing some encouraging signs of recovery after the government opened its borders in phases to international patients, beginning 1 July after a Recovery Movement Control Order began.
Elvie, a women’s health technology company is expanding into China and the US after securing following funding from HSBC in the UK.
South Korean medical devices manufacturer Medifiber has signed a deal with UK medtech company Copper Clothing fior the supply of copper-infused face masks to the UK market.
Petaling Jaya-based corporate healthcare benefits and wellness management platform HealthMetrics has raised $5 as part of a Series A funding in a round led by ACA Investments.
The Farrer Park Company has obtained a S$120 million green loan from United Overseas Bank Limited (UOB), the first such loan for a healthcare facility in Singapore.
The Malaysia Healthcare Travel Council has estimated that there has been a 75% reduction in medical tourism to Malaysia due to the Covid-19 pandemic.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed